Details for 2020732117

Up to date per 04.04.2026

Actions

Title / Product Name

(R)-3-(3-CHLORO-5-FLUORO-2-((4-(1H-PYRAZOL-1-YL)-2-METHYLQUINOLIN-8-YLOXY)METHYL)PHENYL)MORPHOLIN-DERIVATE UND ÄHNLICHE VERBINDUNGEN ALS BRADYKININ (BK) B2 REZEPTOR ANTAGONISTEN ZUR BEHANDLUNG VON HAUTERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020732117

EP Publication Number

3956326

E-Number

1582611

Language

PCT Number

EP20064379

Publication Date

23.02.2022 A

28.06.2023 B1

Registration Date

28.06.2023

AT Publication Date

15.07.2023

Application Date

25.05.2020

Registration Number

Priorities

23.05.2019

19176229

IPC

C07D 413/14 20060101AFI20201127BHEP

Maximum Duration of Protection

25.05.2040

Owner

Pharvaris GmbHGrafenauweg 8 6300 ZugCH

Representative

No representatives present

Inventor

GIBSON, ChristophThulestr. 24 13189 BerlinDE

SAUPE, JoernPomonaring 52 14469 PotsdamDE

AMBROSI, Horst-DieterVokradstrasse 11 10319 BerlinDE

HAUSTEDT, Lars OleSpandauer Str. 1a 14612 FalkenseeDE